查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601597

封闭式药物移附註设备 (CSTD) 的全球市场:类型·零组件·封闭机制·技术·不同地区的预测 (～2032年)

Global Closed System Drug Transfer Device Market Research Report Information By type, By Component, By Closing Mechanism, By Technology By Region- Forecast to 2032
出版日期: | 出版商: Market Research Future | 英文 146 Pages | 订单完成后即时交付

价格

封闭式药物转移装置 (CSTD) 市场规模预计将从 2023 年的 10.7 亿美元增长到 2024 年的 12 亿美元，预测期内复合年增长率为 10.17%，到 2032 年预计将增长到28.7亿美元。医疗保健行业的严格监管和全球癌症发病率的上升正在推动市场发展。

全球癌症发生率不断上升正在推动全球封闭式药物转移装置 (CSTD) 市场的发展。这是因为癌症治疗通常需要使用危险药物，这可能会危及治疗患者的医护人员的健康。使用密封防漏机制可防止这些危险物质释放到环境中。

地理洞察

北美地区将在 2023 年占据最大的市场占有率，预计到 2032 年将达到 99.2 亿美元，预测期内复合年增长率为 9.10%。

预计北美地区所占占有率最大，为 38.14%。强大的研发基础设施和不断增加的癌症患者数量是这一巨大占有率背后的主要因素。 2020 年，美国报告了 1,603,844 例新癌症病例和 602,347 例癌症死亡病例。

亚太地区预计将出现显着增长，并且预计在预测期内增长最快。这是由于大量的区域参与者和较小的进入者正在努力获得市场占有率。

本报告提供全球封闭式药物移附註设备 (CSTD) 的市场调查，彙整市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 全球癌症发生率不断上升
    • 医疗保健产业的严格监管要求
  • 阻碍因素
    • 与 CSTD 相关的高成本
  • 机会
    • 封闭式 CSTD 中技术进步的发展）

第5章 市场要素分析

  • 波特的五力分析
  • COVID-19对全球CSTD市场带来的影响

第6章 全球封闭式药物移附註设备 (CSTD) 市场:各类型

  • 薄膜对薄膜系统
  • 针头无系统

第7章 全球封闭式药物移附註设备 (CSTD) 市场:各零件

  • 注射器安全设备
  • 管瓶存取(点阅)设备
  • 饰品
  • 袋子/线存取(点阅)设备

第8章 全球封闭式药物移附註设备 (CSTD) 市场:封闭机制

  • 推转系统
  • 颜色到颜色对齐系统
  • LEUR锁定系统
  • 点选锁定

第9章 全球封闭式药物移附註设备 (CSTD) 市场:各技术

  • 火车包厢化设备
  • 隔膜为基础的设备
  • 空气过滤设备

第10章 全球封闭式药物移附註设备 (CSTD) 市场:各终端用户

  • 医院·诊所
  • 专门中心
  • 其他

第11章 全球封闭式药物移附註设备 (CSTD) 市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 其他地区
    • 中东
    • 非洲
    • 南美

第12章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票概要
  • 比较分析:主要企业的财务
  • 主要的展开·成长策略

第13章 企业简介

  • B. BRAUN SE
  • JMS CO.LTD.
  • ICU MEDICAL, INC.
  • SIMPLIVIA
  • EQUASHIELD
  • BD
  • BAXTER
  • CORMED
  • YUKON MEDICAL
  • CARAGEN LTD

第14章 资料的引用

Product Code: MRFR/HC/6264-CR

Global Closed System Drug Transfer Device Market Research Report Information By type (Membrane to Membrane and Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, and Air Filtration Devices) By Region- Forecast to 2032

Market Profile

The Closed System Drug Transfer Device Market is expected to have value USD 1.07 billion in 2023. From USD 1.20 billion in 2024 to USD 2.87 billion by 2032 the sector is expected to have a compound annual growth rate (CAGR) of 10.17%. The rigorous regulations of the healthcare industry and the worldwide increasing frequency of cancer are driving development in the market.

Importantly, the growing worldwide cancer prevalence is driving the global closed-system drug transfer device (CSTD) market. This is so because cancer therapy usually requires the use of dangerous drugs that could compromise the health of medical professionals handling them. By use of a closed and leak-proof mechanism, the device is meant to stop the release of these dangerous drugs into the surroundings. Furthermore driving the rising global cancer burden include environmental causes, aging population, better diagnosis tools, and lifestyle choices promoting market expansion.

Segregation of the market

Based on type, the worldwide closed-system drug transfer device market is divided into superfluous systems and membrane-to- membrane systems.

Four categories have been established out of the market: vial access devices, hypodermic safety devices, bag/line access devices, and accessories. The component grounds this division.

Four markets have been developed out of the market: push-to--turn systems, color-to--color alignment systems, leur lock systems, and click-to-lock systems. The closure mechanism forms basis for this classification.

Based on technology, the Closed System Drug Transfer Device Market now consists of air filtration devices, diaphragm-based devices, and compartmentalized devices.

The Market has been segmented into hospitals & clinics, specialty centers, and others based on the end consumer.

Geographic Insights

The Closed System Drug Transfer Device Market has been segmented into the Rest of the World, Asia-Pacific, Europe, and North America based on region. It is anticipated that North America will account for the largest market share in 2023 and reach USD 9.92 billion by 2032, with a compound annual growth rate (CAGR) of 9.10% during the forecast period.

The global CSTD market is expected to be dominated by North America, which holds the largest market share of 38.14%. The strong research and development infrastructure and the increasing prevalence of cancer cases are the primary factors contributing to this substantial market share. For example, in 2020, the United States reported 1,603,844 new cancer cases and 602,347 cancer fatalities.

Asia-Pacific is anticipated to experience substantial growth and is anticipated to be the fastest-growing region during the forecast period. This is attributed to the growing number of new vendors involved in the drug-device system, as numerous regional and small market participants are attempting to leverage their market share.

The Closed System Drug Transfer Device Market is distinguished by the presence of numerous global, regional, and local vendors. The market is intensely competitive, with all participants striving to acquire the largest possible market share. Market growth is significantly influenced by intense competition, frequent changes in government policies, and regulations.

Major Players

Becton, Dickson, and Company, Inc., Baxter International Inc., ICU Medical, Inc., JMS Co.Ltd, B. Braun SE, Simplivia (Israel), Becton, Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland), and Equashield are among the major players in the Closed System Drug Transfer Device Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4. MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF CANCER ACROSS THE GLOBE
    • 4.2.2 STRINGENT REGULATORY REQUIREMENTS WITHIN THE HEALTHCARE INDUSTRY
  • 4.3 RESTRAINTS
    • 4.3.1.HIGH COST ASSOCIATED WITH CSTD
  • 4.4 OPPORTUNITY
    • 4.4.1.GROWING TECHNOLOGICAL ADVANCEMENTS IN CLOSED SYSTEM DRUG TRANSFER DEVICES (CSTDS)

5.MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2.BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET

6.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 MEMBRANE-TO-MEMBRANE SYSTEMS
  • 6.3.NEEDLELESS SYSTEM

7.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
  • 7.2 SYRINGE SAFETY DEVICE
  • 7.3 VIAL ACCESS DEVICES
  • 7.4.ACCESSORIES
  • 7.5 BAG/LINE ACCESS DEVICES

8.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM

  • 8.1 INTRODUCTION
  • 8.2 PUSH TO TURN SYSTEM
  • 8.3 COLOR-TO-COLOR ALIGNMENT SYSTEM
  • 8.4 LEUR LOCK SYSTEMS
  • 8.5.CLICK-TO-LOCK

9.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 COMPARTMENTALIZE DEVICES
  • 9.3 DIAPHRAGM-BASED DEVICES
  • 9.4 AIR FILTRATION DEVICES

10.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & CLINICS
  • 10.3 SPECIALTY CENTERS
  • 10.4 OTHERS

11.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST
    • 11.5.2 AFRICA
    • 11.5.3 LATIN AMERICA

12.COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS,
  • 12.3 COMPETITOR DASHBOARD
  • 12.4 PUBLIC PLAYERS STOCK SUMMARY
  • 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PRODUCT LAUNCH
    • 12.6.2 PRODUCT APPROVAL

13.COMPANY PROFILES

  • 13.1 B. BRAUN SE
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 JMS CO.LTD.
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCTS OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 KEY STRATEGIES
  • 13.3 ICU MEDICAL, INC.
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCT OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 SWOT ANALYSIS
    • 13.3.6 KEY STRATEGIES
  • 13.4 SIMPLIVIA
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 KEY STRATEGIES
  • 13.5 EQUASHIELD
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCTS OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 KEY STRATEGIES
  • 13.6 BD
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 SWOT ANALYSIS
    • 13.6.6 KEY STRATEGIES
  • 13.7 BAXTER
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 CORMED
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 KEY STRATEGIES
  • 13.9 YUKON MEDICAL
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCTS OFFERED
    • 13.9.4 KEY DEVELOPMENTS
    • 13.9.5 SWOT ANALYSIS
    • 13.9.6 KEY STRATEGIES
  • 13.13.CARAGEN LTD
    • 13.13.1 COMPANY OVERVIEW
    • 13.13.2 FINANCIAL OVERVIEW
    • 13.13.3 PRODUCTS OFFERED
    • 13.13.4 KEY DEVELOPMENTS
    • 13.13.5 KEY STRATEGIES

14 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR MEMBRANE-TO-MEMBRANE SYSTEMS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR NEEDLELESS SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR SYRINGE SAFETY DEVICE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR VIAL ACCESS DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR ACCESSORIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR BAG/LINE ACCESS DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR PUSH TO TURN SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COLOR-TO-COLOR ALIGNMENT SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR LEUR LOCK SYSTEMS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR CLICK-TO-LOCK, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COMPARTMENTALIZE DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR DIAPHRAGM-BASED DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR AIR FILTRATION DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR SPECIALTY CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 26 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 27 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 28 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 30 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 31 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 32 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 33 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 34 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 35 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 36 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 37 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 38 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 39 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 40 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 41 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 42 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 43 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 44 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 45 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 46 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 47 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 48 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 49 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 50 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 51 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 53 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 54 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 55 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 56 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 57 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 58 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 59 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 60 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 61 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 63 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 64 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 65 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 66 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 67 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 68 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 69 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 70 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 71 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 72 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 73 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 74 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 75 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 76 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 77 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 78 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 79 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 80 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 87 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 88 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 89 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 90 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 91 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 92 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 93 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 94 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 95 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 96 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 97 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 98 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 99 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 100 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 101 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 102 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 103 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 104 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 105 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 106 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 107 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 108 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 109 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 110 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 111 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 112 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 113 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 114 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 115 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 116 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 117 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 118 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 119 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 120 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 121 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 122 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 123 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 124 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 125 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 126 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 127 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 128 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 129 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 130 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 131 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 132 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 133 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 134 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 135 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 136 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 137 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 138 PRODUCT LAUNCH
  • TABLE 139 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 140 JMS CO.LTD.: PRODUCTS OFFERED
  • TABLE 141 ICU MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 142 SIMPLIVIA: PRODUCTS OFFERED
  • TABLE 143 EQUASHIELD: PRODUCTS OFFERED
  • TABLE 144 BD: PRODUCT OFFERED
  • TABLE 145 BAXTER: PRODUCT OFFERED
  • TABLE 146 CORMED: PRODUCT OFFERED
  • TABLE 147 YUKON MEDICAL: PRODUCTS OFFERED
  • TABLE 148 YUKON MEDICAL: KEY DEVELOPMENTS
  • TABLE 149 CARAGEN LTD: PRODUCT OFFERED

LIST OF FIGURES

  • FIGURE 1 CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
  • FIGURE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; TYPE SEGMENT, (USD MILLION)
  • FIGURE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY TYPE,
  • FIGURE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; COMPONENT SEGMENT, (USD MILLION)
  • FIGURE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY COMPONENT,
  • FIGURE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; CLOSING MECHANISM SEGMENT, (USD MILLION)
  • FIGURE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY CLOSING MECHANISM,
  • FIGURE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; TECHNOLOGY SEGMENT, (USD MILLION)
  • FIGURE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY TECHNOLOGY,
  • FIGURE 18 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; END USER SEGMENT, (USD MILLION)
  • FIGURE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY END USER,
  • FIGURE 21 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 33 REST OF THE WORLD CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 34 REST OF THE WORLD CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 35 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 36 COMPETITOR DASHBOARD: GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
  • FIGURE 37 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 39 JMS CO.LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 ICU MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ICU MEDICAL, INC.: SWOT ANALYSIS
  • FIGURE 42 BD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 BD: SWOT ANALYSIS
  • FIGURE 44 BAXTER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 BAXTER: SWOT ANALYSIS
  • FIGURE 46 YUKON MEDICAL: SWOT ANALYSIS